John Curci

Dr. John Curci

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1997 in Coronary Artery Disease
Verified
Journal Article
Closed access
RTRobert W. Thompson
Robert W. Thompson
SLShixiong Liao
Shixiong Liao
JCJohn Curci
John Curci
Apoptosis is a naturally occurring mechanism of cell death that plays an important role in both normal and pathological remodeling of the vessel wall. Abdominal aortic aneurysms (AAA) represent a unique and dramatic example of vessel wall remodeling characterized by degeneration of the elastic media. Although much attention has been focused on the proteolytic mechanisms that underlie elastin and collagen degradation in AAA, recent studies suggest that depletion of medial smooth muscle cells (SMC) makes an important contribution to this disease by eliminating a cell population capable of directing connective tissue repair. As described in this review, these investigations have revealed that SMC depletion in human aneurysm tissues is accompanied by biochemical, morphological and molecular changes consistent with SMC apoptosis. The exact mechanisms responsible for SMC apoptosis in AAA remain to be elucidated, but current evidence indicates that elevated cellular production of p53 and p21 participates in the process. These findings provide an important new starting point for further investigations on the cellular and molecular mechanisms underlying SMC depletion in AAA and how this process might trigger the accelerated progression of aneurysm disease.

27 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PRPingping Ren
Pingping Ren
MHMichael Hughes
Michael Hughes
SKSwapna Krishnamoorthy
Swapna Krishnamoorthy
SZSili Zou
Sili Zou
LZLin Zhang
Lin Zhang
YSYing H. Shen
Ying H. Shen
Sporadic aortic aneurysm and dissections (AADs) are common vascular diseases that carry a high mortality rate. ADAMTS-4 (a disintegrin-like and metalloproteinase with thrombospondin motifs-4) is a secreted proteinase involved in inflammation and matrix degradation. We previously showed ADAMTS-4 levels were increased in human sporadic descending thoracic AAD (TAAD) samples. Here, we provide evidence that ADAMTS-4 contributes to aortic destruction and sporadic AAD development. In a mouse model of sporadic AAD induced by a high-fat diet and angiotensin II infusion, ADAMTS-4 deficiency (Adamts-4−/−) significantly reduced challenge-induced aortic diameter enlargement, aneurysm formation, dissection and aortic rupture. Aortas in Adamts-4−/− mice showed reduced elastic fibre destruction, versican degradation, macrophage infiltration, and apoptosis. Interestingly, ADAMTS-4 was directly involved in smooth muscle cell (SMC) apoptosis. Under stress, ADAMTS-4 translocated to the nucleus in SMCs, especially in apoptotic SMCs. ADAMTS-4 directly cleaved and degraded poly ADP ribose polymerase-1 (a key molecule in DNA repair and cell survival), leading to SMC apoptosis. Finally, we showed significant ADAMTS-4 expression in aortic tissues from patients with sporadic ascending TAAD, particularly in SMCs. Our findings indicate that ADAMTS-4 induces SMC apoptosis, degrades versican, promotes inflammatory cell infiltration, and thus contributes to sporadic AAD development.

1 May 2016 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
BBB. Timothy Baxter
B. Timothy Baxter
JMJon Matsumura
Jon Matsumura
JCJohn Curci
John Curci
RMRuth McBride
Ruth McBride
WBWilliam C. Blackwelder
William C. Blackwelder
MTMichael L. Terrin
Michael L. Terrin

23 October 2021 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
MNMatthew J. Nordness
Matthew J. Nordness
BBB. Timothy Baxter
B. Timothy Baxter
JMJon Matsumura
Jon Matsumura
MTMichael Terrin
Michael Terrin
KZKevin Zhang
Kevin Zhang
JCJohn Curci
John Curci

1 December 2005 in Seminars in Vascular Surgery
Verified
Journal Article
Closed access
CCChristopher M. Chambers
Christopher M. Chambers
JCJohn Curci
John Curci

1 November 1998 in Advances in Dental Research
Verified
Journal Article
Closed access
PDF file
RTR.W. Thompson
R.W. Thompson
SLS. Liao
S. Liao
JCJohn Curci
John Curci
Abdominal aortic aneurysms (AAA) represent a potentially lethal disorder associated with aging and atherosclerosis. Although current management of AAA is predicated on early detection and elective surgical repair, routine screening for AAA is infrequent, because most AAA are too small to warrant repair when first detected and because there are no therapeutic approaches proven to suppress aneurysm expansion. Basic research on this problem suggests that chronic inflammation and increased local production of elastin-degrading proteinases play prominent roles in the process of aneurysmal degeneration. Members of the matrix metalloproteinases (MMP) family appear to be the most prominent elastases produced in human AAA, suggesting that unique therapeutic targets might exist for aneurysm disease. Studies using a representative animal model for AAA support this view, providing a means for further development of pharmacological approaches to suppress aneurysm expansion. Indeed, recent work indicates that tetracycline derivatives have the potential to interrupt the progressive connective tissue destruction that occurs in AAA, by virtue of their non-antimicrobial properties as MMP inhibitors, and they do so at clinically achievable dose schedules. These findings support the view that MMPs are potentially important pharmacotherapeutic targets in AAA and, moreover, that tetracyclines might be useful in suppressing aneurysm expansion in vivo. Because tetracycline derivatives offer a number of distinct advantages as MMP inhibitors for patients with small AAA, prospective clinical trials of this novel therapeutic strategy can be anticipated in the near future.